.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Baxter
Fuji
Cerilliant
McKesson
US Department of Justice
Federal Trade Commission
AstraZeneca
Daiichi Sankyo

Generated: January 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PN8144

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Eli Lilly And CoAXIRONtestosteroneSOLUTION, METERED;TRANSDERMAL022504-001Nov 23, 2010DISCNYesNo➤ Subscribe➤ SubscribeYTESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
Perrigo Pharma IntlEVAMISTestradiolSPRAY;TRANSDERMAL022014-001Jul 27, 2007RXYesYes➤ Subscribe➤ SubscribeYFEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN
Perrigo Pharma IntlEVAMISTestradiolSPRAY;TRANSDERMAL022014-001Jul 27, 2007RXYesYes➤ Subscribe➤ SubscribeYMENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist